Wordt geladen...
Combinatorial Immunotherapy: PD-1 may not be LAG-ing behind any more
Cancer immunotherapy attempts to harness the immune system by breaking tolerance and generating a robust anticancer response. We have recently demonstrated a synergistic enhancement in tumor clearance following therapeutic, dual PD-1 and LAG-3 blockade. Here, we discuss the implications of these fin...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Landes Bioscience
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3494635/ https://ncbi.nlm.nih.gov/pubmed/23170269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.20593 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|